Papers/PMID:29330704
The Effects of Coenzyme Q10 Supplementation on Blood Pressures Among Patients with Metabolic Diseases: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension2018The record
1 finding · 1 compound · 1 endpoint
What it reported
How to read these marksWhat moved
1 finding
coenzyme Q10 — decreases systolic blood pressure (setting unspecified)
Evidence strength: very limited.Findingreplicated ×1“Results showed that CoQ10 supplementation significantly decreased systolic blood pressure (SBP) (SMD - 0.30; 95% CI - 0.52, - 0.08).”
Quoted verbatim from The Effects of Coenzyme Q10 Supplementation on Blood Pressures Among Patients with Metabolic Diseases: A Systematic Review and Meta-analysis of Randomized Controlled Trials.. - Study
- meta-analysis
- Population
- patients with metabolic diseases, pooled from 17 randomized controlled trials (684 participants)
Effect -0.3 standardised mean difference, 95% CI -0.52 to -0.08
The Effects of Coenzyme Q10 Supplementation on Blood Pressures Among Patients with Metabolic Diseases: A Systematic Review and Meta-analysis of Randomized Controlled Trials.2018PMID:2933070410.1007/s40292-018-0247-2Permalink